BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8503928)

  • 41. Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action.
    Formisano P; Sohn KJ; Miele C; Di Finizio B; Petruzziello A; Riccardi G; Beguinot L; Beguinot F
    J Biol Chem; 1993 Mar; 268(7):5241-8. PubMed ID: 8383132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors.
    Clark S; Konstantopoulos N
    Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):217-23. PubMed ID: 8389126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-induced and constitutive internalization of the insulin receptor.
    Carpentier JL
    Horm Res; 1992; 38(1-2):13-8. PubMed ID: 1339117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture.
    Maegawa H; Tachikawa-Ide R; Ugi S; Iwanishi M; Egawa K; Kikkawa R; Shigeta Y; Kashiwagi A
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1078-82. PubMed ID: 8280122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diacylglycerol directly stimulates the insulin receptor tyrosine kinase.
    Arnold RS; Newton AC
    FEBS Lett; 1996 Feb; 380(1-2):58-62. PubMed ID: 8603747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of glucagon on insulin receptor phosphorylation in intact liver cells.
    Issad T; Young SW; Tavaré JM; Denton RM
    FEBS Lett; 1992 Jan; 296(1):41-5. PubMed ID: 1309705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin down-regulates insulin receptor number and up-regulates insulin receptor affinity in cells expressing a tyrosine kinase-defective insulin receptor.
    Sbraccia P; Wong KY; Brunetti A; Rafaeloff R; Trischitta V; Hawley DM; Goldfine ID
    J Biol Chem; 1990 Mar; 265(9):4902-7. PubMed ID: 2156858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spontaneous phosphorylation of the receptor with high affinity for IgE in transfected fibroblasts.
    Torigoe C; Metzger H
    Biochemistry; 2001 Apr; 40(13):4016-25. PubMed ID: 11300782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phorbol ester induces phosphorylation of the 80 kilodalton murine interleukin 1 receptor at a single threonine residue.
    Bird TA; Woodward A; Jackson JL; Dower SK; Sims JE
    Biochem Biophys Res Commun; 1991 May; 177(1):61-7. PubMed ID: 1828344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sites of in vivo phosphorylation of the T cell tyrosine protein kinase in LSTRA cells and their alteration by tumor-promoting phorbol esters.
    Casnellie JE
    J Biol Chem; 1987 Jul; 262(20):9859-64. PubMed ID: 3496339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin receptor recycling in vascular endothelial cells. Regulation by insulin and phorbol ester.
    Bottaro DP; Bonner-Weir S; King GL
    J Biol Chem; 1989 Apr; 264(10):5916-23. PubMed ID: 2647729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteolytic generation of constitutive tyrosine kinase activity of the human insulin receptor.
    Hsuan JJ; Downward J; Clark S; Waterfield MD
    Biochem J; 1989 Apr; 259(2):519-27. PubMed ID: 2719663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural characterisation of substrate binding to the human insulin receptor tyrosine kinase domain.
    Gao Y; Keane N; Levine BA; Alejos R; Ellis L
    Biochem Soc Trans; 1992 Aug; 20(3):269S. PubMed ID: 1330772
    [No Abstract]   [Full Text] [Related]  

  • 54. The insulin receptor: what triggers and regulates its internalization.
    Carpentier JL
    Prog Histochem Cytochem; 1992; 26(1-4):77-87. PubMed ID: 1484970
    [No Abstract]   [Full Text] [Related]  

  • 55. Cellular expression of mutant insulin receptors interferes with the rapid transcriptional response to both insulin and insulin-like growth factor I.
    Stumpo DJ; Blackshear PJ
    J Biol Chem; 1991 Jan; 266(1):455-60. PubMed ID: 1985910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A basic residue C-terminal to tyrosine compromises its viability as a tyrosine kinase target.
    Keane NE; Quirk PG; Levine BA; Chavanieu A; Calas B; Gao Y; Wei L; Ellis L
    Biochem Soc Trans; 1995 May; 23(2):192S. PubMed ID: 7672214
    [No Abstract]   [Full Text] [Related]  

  • 57. Translation to human temperaments of the tyrosine-kinase active site of the human insulin receptor beta-chain.
    Busby D
    Haematol Blood Transfus; 1989; 32():520-6. PubMed ID: 2625262
    [No Abstract]   [Full Text] [Related]  

  • 58. Lipid modulation of insulin receptor tyrosine kinase activity in cultured cells, animals, and reconstituted systems.
    Crémel G; Ficková M; Klimes I; Leray C; Leray V; Meuillet E; Roques M; Staedel C; Hubert P
    Ann N Y Acad Sci; 1993 Jun; 683():164-71. PubMed ID: 8394663
    [No Abstract]   [Full Text] [Related]  

  • 59. Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes.
    Schmitz-Peiffer C; Biden TJ
    Diabetes; 2008 Jul; 57(7):1774-83. PubMed ID: 18586909
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of serines-967/968 in the juxtamembrane region of the insulin receptor as insulin-stimulated phosphorylation sites.
    Liu F; Roth RA
    Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):471-7. PubMed ID: 8135757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.